Lumonus
Sydney, New South Wales, Australia · Artificial Intelligence, Biotechnology, Health Care
Lumonus is transforming cancer care by empowering providers with user-centric software products and value-added services. Born from firsthand experience with the challenges of delivering quality cancer care globally, Lumonus understands the complexities of managing clinical teams, addressing patient needs, and navigating payor requirements. With a deep appreciation for teamwork, the company levera
Key facts
- Headquarters
- Sydney, New South Wales, Australia
- Employees
- 58
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- www.lumonus.com
- Company page
Recent activity at Lumonus
Lumonus funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Series B | $18.5M |
| Mar 2025 | Seed | $506K |
Leadership
- Nick Stock, Director of Software Engineering
- Lakshay Anand, Senior Software Engineer - Data & AI
- Simon Gurcke, Principal Software & Machine Learning Engineer
- Tim Fox, Chief Product Officer
- Jamie Nash, COO
- Rebecca Edwards, Chief Financial Officer
- Gary Bee, Clinical Solutions Manager
- Keith Hansen, Chief Executive Officer
- Robert King, Dev Ops Engineer
- Thilo Schuler, VP Clinical Data and Ai
- Michelle Stevie, Dosimetrist
- Tom Mastwyk, Director of Data & Ai
Verified email and direct lines for Lumonus’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Lumonus in the news
- Lumonus launches strategic collaboration with leading global cancer center to advance radiation therapy treatment planning - PR Newswire (Apr 07, 2026)
- Extreme galaxy-scale outflows are frequent among luminous early quasars - Nature (May 06, 2026)
- Pat Steir, Painter of Luminous ‘Waterfalls,’ Dies at 87 - The New York Times (Apr 02, 2026)
- Read an extract from Luminous by Silvia Park - New Scientist (May 01, 2026)
- Gunvolt Chronicles: Luminous Avenger iX 3 announced for Nintendo Switch 2 - Nintendo Everything (May 21, 2026)
- Gemini on Android gets a new icon, smarter audio sharing, and a 'Luminous' look - Android Authority (May 15, 2026)
- Flights Halted After ‘Luminous Flying Object’ Sighted Over Berlin Brandenburg Airport - Kyiv Post (Mar 11, 2026)
- NASA Study Helps Explain Limit-Breaking Ultra-Luminous X-Ray Sources - NASA Jet Propulsion Laboratory (JPL) (.gov) (Apr 06, 2023)
Companies similar to Lumonus
- Blackford Analysis · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning
- AKASA · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning
- NTL HEALTHCARE · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning
- C the Signs · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning
- Genoox · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning
About Lumonus: questions and answers
What does Lumonus do?
Lumonus is transforming cancer care by empowering providers with user-centric software products and value-added services. Born from firsthand experience with the challenges of delivering quality cancer care globally, Lumonus understands the complexities of managing clinical teams, addressing patient needs, and navigating payor requirements. With a deep appreciation for teamwork, the company levera
Where is Lumonus headquartered?
Lumonus is headquartered in Sydney, New South Wales, Australia.
How many employees does Lumonus have?
Lumonus has about 58 employees.
Has Lumonus raised funding?
Yes. Fundz has recorded 2 funding events for Lumonus. The most recent, Series B of $18.5M, was in Nov 2025.
Who leads Lumonus?
Keith Hansen is a Chief Executive Officer at Lumonus.
What is the latest news on Lumonus?
On Nov 06, 2025, Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy